Literature DB >> 6111433

The metabolism and excretion of 3-O-methyl-(+)-catechin in the rat, mouse, and marmoset.

A M Hackett, L A Griffiths.   

Abstract

Following oral or intravenous administration to the rat, 3-O-methyl-(+)-catechin was metabolized by methylation of a B-ring phenolic hydroxyl group to 3,3'(or 4')-dimethyl-(+)-catechin, which was further conjugated with glucuronic acid and excreted both in urine and bile. Small amounts of unchanged 3-O-methyl-(+)-catechin was excreted in rat urine following parenteral but not oral administration. Excretion of radioactivity following parenteral administration of 3-O-[14C]methyl-(+)-catechin to the rat and marmoset was similar (approximately 50% in urine and 35% in feces). The mouse excreted 79% of radioactivity in urine and 22% in feces. Radioactivity in mouse and marmoset urine was associated with free dimethyl-(+)-catechin rather than the glucuronide conjugate prevalent in rat urine. Following oral administration to the marmoset, urinary excretion of 14C was lower than in the rat and again the major metabolite was the free dimethyl-(+)-catechin. In bile duct-cannulated rats approximately half of administered radioactivity was excreted in bile. In each experiment more than 85% of the 14C in bile was in the form of dimethylcatechin glucuronide. It is concluded that biological methylation is the major route of 3-O-methyl(+)-catechin metabolism in all species investigated, and that the compound does not undergo ring fission as has been reported in respect of the parent compound, (+)-catechin.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6111433

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  6 in total

1.  New metabolites of the naturally-occurring mutagen, quercetin, the pro-mutagen, rutin and of taxifolin.

Authors:  S Brown; L A Griffiths
Journal:  Experientia       Date:  1983-02-15

2.  Identification of the major urinary metabolites of (+)-catechin and 3-O-methyl-(+)-catechin in man.

Authors:  M Wermeille; E Turin; L A Griffiths
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983       Impact factor: 2.441

3.  3'-O-methyl-(+)-catechin glucuronide and 3'-O-methyl-(+)-catechin sulphate: new urinary metabolites of (+)-catechin in the rat and the marmoset.

Authors:  A M Hackett; I C Shaw; L A Griffiths
Journal:  Experientia       Date:  1982-05-15

4.  The disposition and metabolism of (+)-cyanidanol-3 in patients with alcoholic cirrhosis.

Authors:  M V Smillie; L A Griffiths; P J Male; M M Wermeille
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  The disposition of 3-O-methyl-(+)-catechin in the rat and the marmoset following oral administration.

Authors:  A M Hackett; L A Griffiths
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983       Impact factor: 2.441

Review 6.  Histidine decarboxylase inhibition: a novel approach towards the development of an effective and safe gastric anti-ulcer drug.

Authors:  N S Parmar; G Hennings; O P Gulati
Journal:  Agents Actions       Date:  1984-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.